X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (11287) 11287
Publication (1069) 1069
Newsletter (949) 949
Book Review (158) 158
Book Chapter (98) 98
Conference Proceeding (30) 30
Newspaper Article (22) 22
Reference (10) 10
Dissertation (9) 9
Magazine Article (6) 6
Book / eBook (5) 5
Transcript (5) 5
Data Set (1) 1
Presentation (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (6430) 6430
humans (5538) 5538
animals (5121) 5121
glucagon (4647) 4647
glucagon-like peptide-1 (4540) 4540
male (3583) 3583
endocrinology & metabolism (3532) 3532
type 2 diabetes (3012) 3012
diabetes (2819) 2819
glucose (2440) 2440
insulin (2387) 2387
diabetes mellitus, type 2 - drug therapy (2278) 2278
rats (2079) 2079
female (1955) 1955
mice (1841) 1841
hypoglycemic agents - therapeutic use (1705) 1705
research (1562) 1562
pharmacology & pharmacy (1540) 1540
glp-1 (1538) 1538
peptides (1462) 1462
obesity (1418) 1418
glucagon-like peptide 1 (1396) 1396
liraglutide (1379) 1379
diabetes mellitus (1293) 1293
glucagon-like peptide-1 receptor (1232) 1232
insulin - metabolism (1184) 1184
analysis (1175) 1175
middle aged (1128) 1128
blood glucose - metabolism (1120) 1120
dextrose (1102) 1102
diabetes therapy (1097) 1097
physiological aspects (1048) 1048
exenatide (1044) 1044
glycemic control (1035) 1035
care and treatment (991) 991
biochemistry & molecular biology (961) 961
insulin secretion (943) 943
secretion (912) 912
adult (905) 905
hypoglycemic agents - pharmacology (900) 900
glucagon-like peptide 1 - metabolism (896) 896
peptides - pharmacology (828) 828
insulin resistance (822) 822
internal medicine (813) 813
physiology (810) 810
glucagon-like peptide 1 - analogs & derivatives (794) 794
hypoglycemic agents (788) 788
rodents (764) 764
diabetes mellitus, type 2 - metabolism (755) 755
endocrine system (744) 744
receptors, glucagon - agonists (741) 741
health aspects (737) 737
metabolism (736) 736
aged (714) 714
glucose metabolism (714) 714
exendin-4 (713) 713
diabetes mellitus, type 2 - blood (705) 705
glucagon - pharmacology (704) 704
medicine & public health (700) 700
hypoglycemic agents - administration & dosage (698) 698
drug therapy (693) 693
treatment outcome (692) 692
abridged index medicus (686) 686
hyperglycemia (686) 686
blood glucose - drug effects (680) 680
metformin (667) 667
digestive, oral, and skin physiology (665) 665
insulin-secretion (663) 663
type-2 diabetes-mellitus (651) 651
glucagon - metabolism (645) 645
expression (644) 644
risk factors (643) 643
venoms - pharmacology (635) 635
insulin - blood (630) 630
glucagon-like peptide 1 - therapeutic use (622) 622
glucagon-like peptide-1 receptor - agonists (620) 620
hypoglycemic agents - adverse effects (614) 614
double-blind (612) 612
receptor (611) 611
body weight (610) 610
hormones, hormone substitutes, and hormone antagonists (607) 607
mice, inbred c57bl (605) 605
glucose - metabolism (603) 603
food-intake (596) 596
article (594) 594
peptides - therapeutic use (582) 582
rats, sprague-dawley (582) 582
neurosciences (580) 580
glucagon-like peptide 1 - pharmacology (579) 579
receptors, glucagon - metabolism (579) 579
medical research (567) 567
beta-cell function (565) 565
cell biology (563) 563
dipeptidyl-peptidase iv inhibitors - therapeutic use (541) 541
pancreas (539) 539
clinical trials (531) 531
medicine, research & experimental (526) 526
proteins (525) 525
signal transduction (524) 524
insulin-secreting cells - metabolism (521) 521
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (12047) 12047
German (77) 77
Japanese (41) 41
Spanish (36) 36
French (27) 27
Korean (23) 23
Chinese (16) 16
Italian (15) 15
Russian (12) 12
Czech (11) 11
Polish (4) 4
Swedish (4) 4
Danish (3) 3
Hungarian (3) 3
Arabic (1) 1
Dutch (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
The Lancet, ISSN 0140-6736, 2006, Volume 368, Issue 9548, pp. 1696 - 1705
Glucagon-like peptide 1 (GLP-1) is a gut-derived incretin hormone that stimulates insulin and suppresses glucagon secretion, inhibits gastric emptying, and... 
MEDICINE, GENERAL & INTERNAL | IN-VITRO | METFORMIN-TREATED PATIENTS | HEALTHY-SUBJECTS | 2ND-PHASE INSULIN-SECRETION | IMPROVES GLYCEMIC CONTROL | BETA-CELL APOPTOSIS | IV INHIBITOR | 7-36 AMIDE | IMPROVED GLUCOSE-TOLERANCE | EXENATIDE SYNTHETIC EXENDIN-4 | Triazoles - administration & dosage | Triazoles - adverse effects | Glucagon-Like Peptide 1 - administration & dosage | Humans | Pyrazines - administration & dosage | Glucagon-Like Peptide 1 - biosynthesis | Dipeptidyl Peptidase 4 | Glucagon-Like Peptide 1 - physiology | Pyrazines - therapeutic use | Adenosine Deaminase Inhibitors | Peptides - administration & dosage | Hypoglycemic Agents - administration & dosage | Adamantane - therapeutic use | Pyrrolidines | Venoms - administration & dosage | Nitriles | Sitagliptin Phosphate | Adamantane - administration & dosage | Adamantane - adverse effects | Adamantane - analogs & derivatives | Triazoles - therapeutic use | Glucagon-Like Peptide 1 - classification | Hypoglycemic Agents - therapeutic use | Receptors, Glucagon - agonists | Drug Administration Schedule | Glucagon-Like Peptide 1 - analogs & derivatives | Venoms - adverse effects | Glycoproteins - antagonists & inhibitors | Clinical Trials as Topic | Glucagon-Like Peptide-1 Receptor | Dipeptidyl-Peptidase IV Inhibitors | Pyrazines - adverse effects | Venoms - therapeutic use | Diabetes Mellitus, Type 2 - drug therapy | Glucagon-Like Peptide 1 - adverse effects | Hypoglycemic Agents - adverse effects | Liraglutide | Peptides - adverse effects | Peptides - therapeutic use | Glucagon-Like Peptide 1 - therapeutic use | Type 2 diabetes | Care and treatment | Diagnosis | Glucagon | Analysis | Dosage and administration | Research | Protease inhibitors | Drug therapy | Proteins | Diabetes | Kinases | Insulin | Rodents
Journal Article
Journal Article
Diabetes, Obesity and Metabolism, ISSN 1462-8902, 04/2016, Volume 18, Issue 4, pp. 317 - 332
Journal Article
Diabetes Care, ISSN 0149-5992, 01/2011, Volume 34, Issue 1, pp. 90 - 95
Journal Article
Diabetes, Obesity and Metabolism, ISSN 1462-8902, 09/2017, Volume 19, Issue 9, pp. 1233 - 1241
Journal Article
Diabetes, Obesity and Metabolism, ISSN 1462-8902, 05/2011, Volume 13, Issue 5, pp. 394 - 407
Incretin‐based therapies, such as the injectable glucagon‐like peptide‐1 (GLP‐1) receptor agonists and orally administered dipeptidyl peptidase‐4 (DPP‐4)... 
albiglutide | GLP‐1 analogue | CJC‐1134‐PC | GLP‐1 receptor agonists | antidiabetic drug | type 2 diabetes mellitus | LY2189265 | taspoglutide | exenatide once weekly | incretin therapy | Incretin therapy | Exenatide once weekly | Antidiabetic drug | GLP-1 receptor agonists | GLP-1 analogue | Taspoglutide | CJC-1134-PC | Albiglutide | Type 2 diabetes mellitus | HUMAN GLP-1 ANALOG | INSULIN-SECRETION | OPEN-LABEL | INADEQUATE GLYCEMIC CONTROL | TWICE-DAILY EXENATIDE | BODY-WEIGHT | BETA-CELL-FUNCTION | ENDOCRINOLOGY & METABOLISM | DOUBLE-BLIND | ACUTE-PANCREATITIS | TYPE-2 DIABETES-MELLITUS | Glucagon-Like Peptide 1 - administration & dosage | Recombinant Fusion Proteins - pharmacology | Glycated Hemoglobin A - metabolism | Humans | Glycated Hemoglobin A - drug effects | Male | Immunoglobulin Fc Fragments - administration & dosage | Dipeptidyl-Peptidase IV Inhibitors - pharmacology | Hyperglycemia - drug therapy | Peptides - administration & dosage | Hypoglycemic Agents - administration & dosage | Venoms - administration & dosage | Female | Glucagon-Like Peptides - analogs & derivatives | Recombinant Fusion Proteins - administration & dosage | Receptors, Glucagon - agonists | Glucagon-Like Peptide 1 - analogs & derivatives | Glucagon-Like Peptide 1 - pharmacology | Biomarkers - blood | Dipeptidyl-Peptidase IV Inhibitors - administration & dosage | Hypoglycemic Agents - pharmacology | Peptides - pharmacology | Glucagon-Like Peptide-1 Receptor | Immunoglobulin Fc Fragments - pharmacology | Venoms - pharmacology | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Liraglutide | Type 2 diabetes | Antigen-antibody reactions | Hyperglycemia | Peptides | Heterocyclic compounds | Glycosylated hemoglobin | Hypoglycemic agents | Glucose | Dextrose
Journal Article